CASP3 and lymphoma: Doxorubicin is one of the commonly used cytotoxic drugs in the chemotherapy of DLBCL, which was reported to suppress lymphoma growth by inducting caspase 3-dependent apoptosis (Tayeh and Ofir, 2018).